Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
Leman Biotech
Leman Biotech Co., Ltd, originating from Switzerland, is a clinical-stage innovative immunometabolic drug development company focused on novel tumor immunotherapy drugs. Founded by Professor Li…
Leman Biotech
Leman Biotech Co., Ltd, originating from Switzerland, is a clinical-stage innovative immunometabolic drug development company focused on novel tumor immunotherapy drugs. Founded by Professor Li…
TL;DR
Stage: Clinical-stage
Core technology: META 10 metabolic reprogramming for T cells
Flagship programs: Metabolically enhanced CAR‑T (e.g., META10‑19, META10‑BCMA)
Notable funding: Angel rounds totaling ~USD 18–20M (including USD 11M and USD 7M rounds)
Founding origin: EPFL spin‑out (Prof. Li Tang team) in partnership with XtalPi
Company Overview
Problem Domain
Tumor immunotherapy; T cell exhaustion and metabolic dysfunction in cancer
Founded
2021
Industry
Biotechnology
Funding Track Record
11000000
Reported as an $11M angel round in company announcements
7000000
Announced as USD 7M financing to accelerate clinical development
Series A listed in third‑party funding profiles; amount not disclosed in provided evidence
Investor Signal
“Fuho Capital, Tiantu Capital, XtalPi, Yunfan Technology Investment, Junyi Holdings, Tiantu Capital, XtalPi”